A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.

After a bladder cancer diagnosis, one patient wants to raise awareness among women about this disease that can be mistaken for a UTI.

MUSC’s pipeline programs build the skills of underrepresented students and prepare them for careers in health care and medical research.

Leukogene Therapeutics Inc. introduces a promising therapy to treat multiple cancers and hopes to become flagship entity for MUSC’s innovation ecosystem.

For people with HIV, the risk of anal cancer varies significantly depending on the region of the country where they live.

A lung cancer diagnosis has focused Laura Reed's mind on how she wants to live her life.

After bladder cancer diagnosis, writer tells doctor: "I am going to live to 115. I have books to write."

After melanoma surgery, hairdresser Carol Helton is spreading the word at her hair salon about staying on top of suspicious moles.

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.